IQ-AI Regulatory News (IQAI)

Flying Brands PLC

("Flying Brands" or the "Company")

Imaging Biometrics and QMENTA announce a partnership to increase accuracy in research.

Imaging Biometrics®, LLC ("IB"), a subsidiary of Flying Brands Limited (LON:FBDU), announces today that it has entered into a partnership to accelerate neuroscience research and increase accuracy in diagnostics support. Imaging Biometrics will integrate all IB modules; IB Neuro, IB Delta T1 Maps, IB Diffusion, and IB DCE onto the cloud-based QMENTA platform that provides advanced data analysis and management for neuro experts.

The integration of IB's software is the first FDA cleared option on the QMENTA platform to be uploaded via its Software Development Kit ("SDK"). The SDK has been developed by QMENTA's engineers to enable third party companies or researchers with algorithms to integrate them on the platform to easily share them with the neuroscience community. This goes along with QMENTA's aim to bolster collaboration, whether it be between researchers, neurologists, developers, or even with other companies.

Quote from Imaging Biometrics' CEO, Michael Schmainda

"Our partnership with QMENTA enables efficient and immediate access to our quantitative imaging solutions to those involved in clinical trials and research. It is exciting to be part of QMENTA's neuro-centric platform and helping advance the understanding of neurological disorders."

Quote from QMENTA's CEO, Paulo Rodrigues, PhD

"We are very proud of this new partnership as it is the first FDA cleared tool we will be implementing on our SDK. We believe this partnership will improve our customers' satisfaction, because they know they can trust and rely on powerful and efficient tools such as the ones that Imaging Biometrics is developing." 

About the partners

Imaging Biometrics, a subsidiary of Flying Brands Limited (LON:FBDU), develops and provides visualisation and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualisation software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.

QMENTA offers a cloud-based platform to streamline the medical imaging workflow for running clinical trials. QMENTA's aim is to accelerate the discovery and development of new treatments for neurological diseases using state-of-the-art image processing techniques. QMENTA has been growing since 2013 in EU & US, now supporting many multi-center studies and a number of clinical trials. The company was named "Best New Radiology Vendor" in 2017 by Aunt Minnie and was a European Winner for Accenture's Healthtech Innovation Challenge. More recently, QMENTA has been invited by Sanofi to attend VivaTech in Paris and won one of the Sanofi Tech Lab challenges for its innovative technology. For more information on the company, visit www.qmenta.com.

Flying Brands Limited (Ticker:FBDU) is the parent company of StoneChecker® and Imaging Biometrics® focused on advanced and state of the art medical software and services. (www.flyingbrands.co.uk).

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please contact:

-Ends-